Goldman Sachs Group Inc Ocugen, Inc. Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 887,052 shares of OCGN stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
887,052
Previous 600,679 47.67%
Holding current value
$1.48 Million
Previous $426,000 101.88%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$0.58 - $1.2 $166,096 - $343,647
286,373 Added 47.67%
887,052 $860,000
Q1 2025

May 09, 2025
SELL
$0.52 - $0.9 $117,087 - $202,651
-225,168 Reduced 27.27%
600,679 $426,000
Q4 2024

Feb 11, 2025
SELL
$0.72 - $1.08 $76,960 - $115,441
-106,890 Reduced 11.46%
825,847 $660,000
Q3 2024

Nov 14, 2024
BUY
$0.98 - $1.95 $169,831 - $337,929
173,297 Added 22.82%
932,737 $923,000
Q2 2024

Aug 13, 2024
SELL
$1.18 - $1.98 $2.18 Million - $3.66 Million
-1,848,185 Reduced 70.88%
759,440 $1.18 Million
Q1 2024

May 15, 2024
BUY
$0.5 - $1.83 $1.3 Million - $4.77 Million
2,607,625 New
2,607,625 $4.28 Million
Q2 2023

May 14, 2024
SELL
$0.45 - $0.88 $285,403 - $558,123
-634,231 Reduced 89.97%
70,669 $38,000
Q2 2023

Aug 14, 2023
SELL
$0.45 - $0.88 $285,403 - $558,123
-634,231 Reduced 89.97%
70,669 $38,000
Q1 2023

May 14, 2024
SELL
$0.82 - $1.33 $689,058 - $1.12 Million
-840,315 Reduced 54.38%
704,900 $599,000
Q1 2023

May 11, 2023
SELL
$0.82 - $1.33 $689,058 - $1.12 Million
-840,315 Reduced 54.38%
704,900 $599,000
Q4 2022

May 14, 2024
SELL
$1.11 - $1.87 $498,062 - $839,078
-448,705 Reduced 22.5%
1,545,215 $2.01 Million
Q4 2022

Feb 13, 2023
SELL
$1.11 - $1.87 $498,062 - $839,078
-448,705 Reduced 22.5%
1,545,215 $2.01 Million
Q3 2022

May 14, 2024
BUY
$1.75 - $3.1 $728,448 - $1.29 Million
416,256 Added 26.38%
1,993,920 $3.55 Million
Q3 2022

Nov 10, 2022
BUY
$1.75 - $3.1 $728,448 - $1.29 Million
416,256 Added 26.38%
1,993,920 $3.55 Million
Q2 2022

May 14, 2024
BUY
$1.83 - $3.45 $2.89 Million - $5.44 Million
1,577,664 New
1,577,664 $3.58 Million
Q2 2022

Aug 15, 2022
BUY
$1.83 - $3.45 $1.09 Million - $2.06 Million
596,736 Added 60.83%
1,577,664 $3.58 Million
Q1 2022

May 16, 2022
BUY
$2.34 - $4.72 $1.78 Million - $3.59 Million
760,306 Added 344.62%
980,928 $3.24 Million
Q4 2021

Feb 14, 2022
SELL
$4.38 - $15.67 $20,923 - $74,855
-4,777 Reduced 2.12%
220,622 $1 Million
Q3 2021

Nov 10, 2021
BUY
$6.36 - $8.51 $1.43 Million - $1.92 Million
225,399 New
225,399 $1.62 Million

Others Institutions Holding OCGN

# of Institutions
112
Shares Held
64.6M
Call Options Held
604K
Put Options Held
253K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $362M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email